<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0006">
 <label>6.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Hézode</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Forestier</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Dusheiko</surname>
    <given-names>G</given-names>
   </name>, 
   <etal>et al;</etal>
  </person-group>
  <person-group>
   <collab>PROVE2 Study Team</collab>
  </person-group>
  <article-title>Telaprevir and peginterferon with or without ribavirin for chronic HCV infection</article-title>. 
  <source>N Engl J Med</source>
  <year>2009</year>; 
  <volume>360</volume>:
  <fpage>1839</fpage>–
  <lpage>50</lpage>.
  <pub-id pub-id-type="pmid">19403903</pub-id>
 </mixed-citation>
</ref>
